| Identification | Back Directory | [Name]
mepolizumab | [CAS]
196078-29-2 | [Synonyms]
Bosatria
Sb 240563
mepolizumab
Research Grade Mepolizumab(DHC13602)
Immunoglobulin G1, anti-(human interleukin 5) (human-mouse monoclonal sb-240563 gamma1-chain), disulfide with human-mouse monoclonal sb-240563 kappa-chain, dimer
eosinophil proliferation,neutralizes interleukin-5,Interleukin Related,IL-5,Mepolizumab,eosinophilic granulomatosis,humanized monoclonal antibody,polyangiitis,Inhibitor,SB240563,EGPA,activation,SB-240563,eosinophilic asthma,survival,inhibit |
| Hazard Information | Back Directory | [Uses]
Immunomodulator (monoclonal antibody). | [Clinical Use]
Humanised IL-5 antagonist monoclonal antibody:
Treatment of severe refractory eosinophilic asthma | [Drug interactions]
Potentially hazardous interactions with other drugs
Vaccines: avoid concomitant use with live vaccines | [Metabolism]
Mepolizumab is a humanised IgG1 monoclonal antibody
degraded by proteolytic enzymes which are widely
distributed in the body and not restricted to hepatic
tissue | [storage]
Store at -20°C |
|
|